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Abstract 
Ultrasonic aspirator (UA), or the Cavitron Ultrasonic 
Aspirator (CUSA) as it is commonly referred to, utilizes 
ultrasonic waves of variable range of frequencies to 
disintegrate and excise tumours. It is developed as a 
substitute of bipolar diathermy; a tool commonly 
employed for coagulation that uses focussed electric 
current and may damage tissues by virtue of contact, or 
by the heat that it produces. Over the last 30 years, CUSA 
has become increasingly popular in several soft tissue 
surgeries, especially brain and spine tumour resection, as 
it allows reduction in the use of bipolar diathermy. It is 
assumed that CUSA improves both surgical safety and 
clinical outcomes, and also reduces surgical time. Herein 
the authors have reviewed the available literature on the 
advantages of CUSA. 
Keywords: Ultrasonic aspirator, CUSA, Brain tumour, 
Spinal cord tumour. 
Introduction 
Ultrasonic aspirator (UA) is a useful piece of equipment 
for surgeries on soft tissues, especially brain and spine 
tumour resection. It is even considered essential in 
certain cases. UA employs high frequency ultrasound 
waves for fragmentation of the tumour tissue, which it 
then aspirates. It is claimed that it allows a surgeon to 
perform safe and fast debulking of tumours with 
minimal risk to surrounding structures.1 Neural tissue 
and blood vessels are also relatively protected during 
dissection, reducing surgical time and intra-operative 
blood loss, thereby improving surgical efficiency and 
patient outcomes.2-5 By virtue of its design, as compared 
to conventional methods of tumour removal using 
bipolars, suction and forceps; Cavitron Ultrasonic 
Aspirator (CUSA), a commonly used brand of UA, allows 
surgeons to remove tumours without causing much 
traction or manipulation.3 It also allows users to irrigate 
the operative field that improves visibility and tissue 
identification. Whereas older models were bulky and 
difficult to use, newer models are not only better 
designed, but also allow additional functions. 
Currently, UA is being employed in endoscopic as well as 
open neurosurgery for resection of brain and spinal cord 
tumours.6-8 In this review, we have summarized the 
existing literature on the use of CUSA in neurosurgical 
procedures. 
Review of Evidence  
In one of the earliest studies that assessed the role of 
CUSA, Fasano et al., had reported their experience of 
using UA in 52 brain tumour resections, including both 
intra-axial and extra-axial lesions.8 They found several 
advantages of UA compared to conventional surgical 
techniques such as provision of good visibility of the 
operative field, better removal of abnormal tissue, 
sparing of major vessels with haemostatic effect on 
vessels less than 1mm diameter and negligible brain 
tissue manipulation, traction and thermal effects on 
adjacent tissue.8 Soon after, Fred Epstein published a 
detailed description on the use of CUSA for different 
brain tumours, he recommended that with the use of 
UA, the tumour can be debulked from the centre which 
makes it easier to dissect the capsule from adjacent 
neural structures and achieve gross total resection.9 
Since then, UA has been used in the treatment of various 
neoplasms including meningiomas, gliomas and 
posterior fossa tumours. Tang et al., published their 
experience with CUSA Excel, an advanced variant of the 
UA, in 10 patients with anterior and middle skull-base 
meningiomas. They had achieved complete tumour 
resection in all the cases in their series, and 
recommended routine use of CUSA in all meningioma 
cases as it helped in avoiding damage to the 
neurovascular structures.10 
More recently, several authors have published their 
experience with UA in endoscopic surgeries, both for 
skull base and intraventricular tumours. Ledderose et al., 
reported their experience with Sonopet UA, another 
brand of UA, for the management of anterior skull base 
tumours through trans-nasal approach, in a feasibility 
trial conducted on 10 patients. They found it to be useful 
especially for highly vascularised tumours, by reducing 
surgical complications and thereby improving 
outcomes, but also encountered difficulty in reaching 
tumours away from the midline via trans-nasal route due 
to non-flexible tip of the UA.11 Similar results were 
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reported by Oertel et al., where 3 patients with 
obstructive hydrocephalus and 2 patients with pituitary 
macroadenoma were treated using UA coupled with 
neuroendoscope, and the lesions were removed without 
significant complications.12 Cinalli et al., reported their 
experience with UA in endoscopic management of 
intraventricular, paraventricular and suprasellar tumours 
in 12 paediatric patients, and reported good outcomes, 
with gross total or near total resection in up to half of 
their patients.13 Although some earlier reports on 
endoscope coupled UA, had reported temporary loss of 
visibility due to air bubbles, Cinalli et al. did not 
encounter this problem.13,14 Apart from the surgical 
benefits of using UA, some authors have also reported 
diagnostic advantages of using UA. In a retrospective 
study, Rao et al., analysed 73 CNS tumour samples 
obtained via CUSA, and compared the findings with 
those on samples obtained via conventional methods. 
They recommended that tumour sample collected in the 
UA suction bottle could also be sent for 
histopathological analysis, although such tissue showed 
greater anatomical distortion compared to tissue 
obtained through conventional methods, particularly in 
glial neoplasms and medulloblastoma.15 
Lately, CUSA has also been utilized in the resection of 
spinal tumours with favourable results. Chou et al., 
published a retrospective case series of paediatric 
spinal cord tumours operated at their centre over a ten-
year period. Seventy-five children with spinal tumours, 
both intradural and extradural, were included and CUSA 
was employed for tumour resection along with 
conventional method. They reported gross total 
resection in 45% patients, and 91% patients were 
ambulatory at 3 months after surgery compared to 75% 
before surgery.16 Barzilai et al. performed a 
retrospective review of 6 patients who had undergone 
resection of intramedullary spinal cord tumours using 
tip of the UA for intra-operative neurological 
monitoring. They reported favourable outcomes and 
recommended that fusing UA and electrophysiological 
monitoring probe improves safety along with better 
tumour resection.17 
There are also negative reports of UA usage. 
Ridderheim et al., reported a case of vestibular 
schwannoma, where the use of CUSA intra-operatively 
was associated with some cases of post-operative 
seventh cranial nerve palsy, which could likely be due 
to transmission of strong ultrasonic waves through 
petrous temporal bone.18 Another important limitation 
includes the inability of CUSA to resect calcified, 
fibrous and firm consistency lesions, and to coagulate 
larger sized blood vessels for which conventional 
diathermy/haemostat agents are employed.9 This 
however may not be a limitation in the latest, advanced 
models. In a case control study of 40 patients, Tuncer et 
al., compared the operating time of patients in whom 
UA was used to those cases where UA was not 
employed.19 They reported longer duration of surgery 
with UA usage, and cited lack of adequate training of 
neurosurgeons as the likely cause, recommending 
appropriate training of staff and subsequent studies to 
assess the effect.19 
Conclusion 
Although no randomised control trials have been 
conducted, there is sufficient evidence in literature to 
support the use of UA in brain tumour resection, and 
though there are only few smaller case series on its use in 
spinal tumours, no negative features have been reported. 
It allows safe tumour resection, and thus improves 
surgical outcome. 
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